Qilu Pharmaceutical Co., Ltd. was established in 1958. It focus on developing, manufacturing and marketing of generic drugs in therapeutic area of Oncology, Cerebrovascular & Cardiovascular, Infections, Psychological and Neurological system, Respiratory system, Ophthalmological Diseases etc., as well as Active Pharmaceutical Ingredients.
The company is strictly complying with GMP. For your reference, among the 5 munufacturing sites of Qilu, 3 of them has been approved by USFDA/EDQM/MCC while the other 2 are newly constructed.
The company has a comlete range of dosaged forms, such as liquid injection, powder for injection, tablets, capsules, granules, ointment, eyedrops, etc.
We registered our products (both APIs&finished formulations) and export to many counties including India, Japan, Korea, India, Bangalore, Pakistan, South Africa, Brazil, USA, Germany, Itlay, Greece, Turkey, etc.
Now we are vigorously registering our products (especially APIs) in more regulated countries including EU, USA, Canada, Australia, etc. The latest process is --we have passed the inspection of MHRA, UK for one of our APIs in Nov. 2006.